{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T22:48:51Z","timestamp":1789858131635,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anales de Pediatr\u00eda"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.anpedi.2008.12.011","type":"journal-article","created":{"date-parts":[[2009,6,10]],"date-time":"2009-06-10T09:06:11Z","timestamp":1244624771000},"page":"354-361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Efectividad del etanercept en el tratamiento de la artritis idiop\u00e1tica juvenil"],"prefix":"10.1016","volume":"70","author":[{"given":"J.","family":"de Inocencio Arocena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Merino Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"\u00c1lvarez Madrid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Garc\u00eda-Consuegra Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anpedi.2008.12.011_bib1","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1542\/peds.90.6.950","article-title":"Epidemiology of juvenile chronic arthritis in southwestern Sweden: A 5-year prospective population study","volume":"90","author":"G\u00e4re","year":"1992","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2008.12.011_bib2","first-page":"346","article-title":"Registro Nacional de Enfermedades Reum\u00e1ticas Infantiles","volume":"45","year":"1996","journal-title":"An Esp Pediatr"},{"key":"10.1016\/j.anpedi.2008.12.011_bib3","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: Second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.anpedi.2008.12.011_bib4","unstructured":"Merino R, De Inocencio J, Garc\u00eda-Consuegra J. Evaluation of revised International League of Associations for Rheumatology classification criteria for juvenile idiopathic arthritis in Spanish children (Edmonton 2001). J Rheumatol. 2005;32:559\u201361."},{"key":"10.1016\/j.anpedi.2008.12.011_bib5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10067-007-0654-6","article-title":"Biologics for the treatment of juvenile idiopathic arthritis: A systematic review and critical analysis of the evidence","volume":"27","author":"Gartlehner","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.anpedi.2008.12.011_bib6","first-page":"338","article-title":"Artritis idiop\u00e1tica juvenil: tratamiento actual y perspectivas terap\u00e9uticas","volume":"30","author":"Garc\u00eda-Consuegra Molina","year":"2003","journal-title":"Rev Esp Reumatol"},{"key":"10.1016\/j.anpedi.2008.12.011_bib7","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJM200003163421103","article-title":"Etanercept in children with polyarticular juvenile rheumatoid arthritis","volume":"342","author":"Lovell","year":"2000","journal-title":"New Engl J Med"},{"key":"10.1016\/j.anpedi.2008.12.011_bib8","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1002\/art.22838","article-title":"A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis","volume":"56","author":"Ruperto","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.anpedi.2008.12.011_bib9","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa0706290","article-title":"Adalimumab with or without methotrexate in juvenile rheumatoid arthritis","volume":"359","author":"Lovell","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anpedi.2008.12.011_bib10","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.20050473","article-title":"Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade","volume":"201","author":"Pascual","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.anpedi.2008.12.011_bib11","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(08)60454-7","article-title":"Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: A randomised, double-blind, placebo-controlled, withdrawal phase iii trial","volume":"371","author":"Yokota","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.anpedi.2008.12.011_bib12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0140-6736(08)60998-8","article-title":"Abatacept in children with juvenile idiopathic arthritis: A randomised, double-blind, placebo-controlled withdrawal trial","volume":"372","author":"Ruperto","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.anpedi.2008.12.011_bib13","unstructured":"Mulero Mendoza J, Vera Mendoza M. Infliximab y etanercept hoy. Inf Ter Sist Nac Salud 2003;27:168-74 [citado 12 Agosto 2008]. Disponible en: URL: http:\/\/www.msc.es\/biblioPublic\/publicaciones\/docs\/vol27_6infliximab.pdf."},{"key":"10.1016\/j.anpedi.2008.12.011_bib14","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/1529-0131(199707)40:7<1202::AID-ART3>3.0.CO;2-R","article-title":"Preliminary definition of improvement in juvenile arthritis","volume":"40","author":"Giannini","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"Suppl. 23","key":"10.1016\/j.anpedi.2008.12.011_bib15","first-page":"S141","article-title":"The European Spanish version of the childhood health assessment questionnaire (CHAQ) and the child health questionnaire (CHQ)","volume":"19","author":"De Inocencio","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.anpedi.2008.12.011_bib16","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/art.21784","article-title":"A comparison of response criteria to evaluate therapeutic response in patients with juvenile idiopathic arthritis treated with methotrexate and\/or anti-tumor necrosis factor \u03b1 agents","volume":"54","author":"Lurati","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.anpedi.2008.12.011_bib17","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1136\/ard.2003.014886","article-title":"The German etanercept registry for treatment of juvenile idiopathic arthritis","volume":"63","author":"Horneff","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.anpedi.2008.12.011_bib18","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/art.10885","article-title":"Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type","volume":"48","author":"Quartier","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"supl 3","key":"10.1016\/j.anpedi.2008.12.011_bib19","first-page":"252","article-title":"Tratamiento con etanercept en la artritis idiop\u00e1tica juvenil (AIJ): resultados de un registro retrospectivo multic\u00e9ntrico espa\u00f1ol","volume":"64","author":"Calvo Penad\u00e9s","year":"2006","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.anpedi.2008.12.011_bib20","first-page":"935","article-title":"Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis","volume":"32","author":"Kimura","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.anpedi.2008.12.011_bib21","first-page":"763","article-title":"Response of systemic onset juvenile rheumatoid arthritis to etanercept: Is the glass half full or half empty?","volume":"32","author":"Eberhard","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.anpedi.2008.12.011_bib22","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/rheumatology\/kem069","article-title":"Improvement in patient-reported outcomes for patients with ankylosing spondylitis treated with etanercept 50mg once-weekly and 25mg twice-weekly","volume":"46","author":"Braun","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.anpedi.2008.12.011_bib23","first-page":"2055","article-title":"Prolonged efficacy of etanercept in refractory enthesitis-related arthritis","volume":"31","author":"Henrickson","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.anpedi.2008.12.011_bib24","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1002\/art.21121","article-title":"Anti-tumor necrosis factor \u03b1 blockade in the treatment of juvenile spondylarthropathy","volume":"52","author":"Tse","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.anpedi.2008.12.011_bib25","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jpeds.2006.08.044","article-title":"Risk of new-onset uveitis in patients with juvenile idiopathic arthritis treated with anti-TNF\u03b1 agents","volume":"149","author":"Saurenmann","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.anpedi.2008.12.011_bib26","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/rheumatology\/keh658","article-title":"Etanercept and uveitis in patients with juvenile idiopathic arthritis","volume":"44","author":"Schmeling","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.anpedi.2008.12.011_bib27","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/art.20904","article-title":"A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis","volume":"53","author":"Smith","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.anpedi.2008.12.011_bib28","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/BOR.0b013e32825f5481","article-title":"Use of tumor necrosis factor inhibitors in uveitis","volume":"19","author":"Rabinovich","year":"2007","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.anpedi.2008.12.011_bib29","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/ICU.0b013e3282f03d42","article-title":"Biologics in the treatment of uveitis","volume":"18","author":"Imrie","year":"2007","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.anpedi.2008.12.011_bib30","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/art.11137","article-title":"Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: A multicenter active-surveillance report","volume":"48","author":"G\u00f3mez-Reino","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"Supl 35","key":"10.1016\/j.anpedi.2008.12.011_bib31","first-page":"S134","article-title":"Demyelination and inhibition of tumor necrosis factor (TNF)","volume":"22","author":"Magnano","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.anpedi.2008.12.011_bib32","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/mus.20924","article-title":"Tumor necrosis factor-\u03b1 antagonists and neuropathy","volume":"37","author":"St\u00fcbgen","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.anpedi.2008.12.011_bib33","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/rheumatology\/keh468","article-title":"Optic neuritis associated with etanercept therapy in two patients with extended oligoarticular juvenile idiopathic arthritis","volume":"44","author":"Tauber","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.anpedi.2008.12.011_bib34","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1157\/13116224","article-title":"S\u00edndrome de activaci\u00f3n macrof\u00e1gica y artritis idiop\u00e1tica juvenil. Resultados de un estudio multic\u00e9ntrico","volume":"68","author":"Garc\u00eda-Consuegra Molina","year":"2008","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.anpedi.2008.12.011_bib35","first-page":"2120","article-title":"Etanercept in the treatment of macrophage activation syndrome","volume":"28","author":"Prahalad","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.anpedi.2008.12.011_bib36","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/pbc.21019","article-title":"Etanercept for therapy-resistant macrophage activation syndrome","volume":"50","author":"Makay","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.anpedi.2008.12.011_bib37","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/ard.2007.069484","article-title":"Focus on adverse events of tumour necrosis factor alpha blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients","volume":"67","author":"Gerloni","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.anpedi.2008.12.011_bib38","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1002\/art.21885","article-title":"Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis","volume":"54","author":"Lovell","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.anpedi.2008.12.011_bib39","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/art.23427","article-title":"Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis","volume":"58","author":"Lovell","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.anpedi.2008.12.011_bib40","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cyto.2008.01.007","article-title":"The significance of persistent newly developed autoantibodies in JIA patients under long-term anti-TNF treatment","volume":"42","author":"Kanakoudi-Tsakalidou","year":"2008","journal-title":"Cytokine"}],"container-title":["Anales de Pediatr\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403309001696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403309001696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:44:22Z","timestamp":1761662662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1695403309001696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S1695403309001696"],"URL":"https:\/\/doi.org\/10.1016\/j.anpedi.2008.12.011","relation":{},"ISSN":["1695-4033"],"issn-type":[{"value":"1695-4033","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efectividad del etanercept en el tratamiento de la artritis idiop\u00e1tica juvenil","name":"articletitle","label":"Article Title"},{"value":"Anales de Pediatr\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anpedi.2008.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}